Life Sciences

From biotech to pharmaceuticals, medical devices to diagnostics—as you make history, we'll be with you every step of the way.

#1

in loans and cash management1

#1

in overall customer satisfaction2

$11.5B

firmwide investment in technology3

What We Do

Whether your biotechnology, pharmaceutical, medical device, or tools and diagnostics company is pre-clinical, in the early stages of trials, completing the regulatory approvals process or already commercialized, our industry specialists will help you keep it positioned for growth.

 

Establish a Banking Relationship That Grows With You

As specialists who focus on providing banking solutions exclusively for life sciences companies, we understand the financial and regulatory challenges you face through every step of your development. We can help you navigate these challenges so you can achieve your long-term goals.

 

Customized Access to Resources

Your local banking relationship can help provide you with access to the full resources of our firm, regardless of your company’s current size or needs. Whether it’s investment banking solutions, support for your domestic and international expansion, or credit, financing and treasury services—including the right commercial card program—we provide a seamless connection to what you need, when you need it.

 

Your Connection to Global Resources

With offices throughout the world and a long history of doing business in foreign markets, we can help your life sciences company navigate the complexities of expanding and maintaining international operations.

 

An Easier Way to Conduct Business

Our online platform, which scales to your company’s needs, enables you to manage your business operations with less effort and greater confidence. By centralizing your banking activities on a single digital dashboard, it literally puts your finances at your fingertips—anytime and anywhere.

 

Providing Powerful and Secure Technology

Just as technological advancements affect your industry and its opportunities, it drives change in ours. As a firm, we continuously invest in our own technology platforms. This enables you to confidently operate with greater efficiency and security, while making more informed decisions in support of your day-to-day operations and growth.

 

Ongoing Insight Into Your Industry

Through our global footprint, our clients gain access to vital industry networks and expertise from the annual J.P. Morgan Health Conference, along with the regular insights and research of Morgan Markets.


Connect with an Expert

Contact us

Who We Are

Peter Meath

Peter Meath

Peter Meath

Industry Head, J.P. Morgan Life Sciences

Kathleen Addison

Kathleen Addison

Kathleen Addison

Executive Director

Chris Barrow

Chris Barrow

Chris Barrow

Executive Director

Derek Brunelle

Derek Brunelle

Derek Brunelle

Executive Director

Susan Crinnion

Susan Crinnion

Susan Crinnion

Executive Director

Kevin Filer

Kevin Filer

Kevin Filer

Vice President

Mike Gietl

Mike Gietl

Mike Gietl

Executive Director

Margaret Kim

Margaret Kim

Margaret Kim

Executive Director

Linda Le Beau

Linda Le Beau

Linda Le Beau

Executive Director

Joe Lee

Joe Lee

Joe Lee

Vice President

George Santo

George Santo

George Santo

Vice President

Brett Shealy

Brett Shealy

Brett Shealy

Vice President

Anna Valladolid

Anna Valladolid

Anna Valladolid

Executive Director

Christine Hurley

Christine Hurley

Christine Hurley

Associate

P. John Chorzepa

P. John Chorpeza

P. John Chorzepa

Associate

Melissa Conner

Melissa Conner

Melissa Conner

Associate

Related Products and Services

Best-in-class financing and treasury solutions to support a broad range of corporations, institutions, governments and real estate investors

Get in Touch and Stay Informed

icon
Loading...

1 Greenwich Associates ranked us as its 2017 Best Brand in Middle Market Banking for loans or lines of credit, cash management, trade finance, investment banking and on an overall basis.
2 CFO Magazine’s 2017 Commercial Banking Survey awarded us four No.1 spots. These were for overall satisfaction, customer relationships, perceived satisfaction and transaction/payments processing.
3 Through a firmwide initiative to remain at the forefront of innovation, we are committed to investing $11.5 billion annually to further enhance our infrastructure for your overall experience.